-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

605.O1.6 605. Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases: Diverse Mechanisms of Drug Resistance

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 7:00 AM-8:30 AM
W312, Level 3 (Orange County Convention Center)
Moderators:
Jun J Yang, PhD, St. Jude Children's Research Hospital and Monique L. Den Boer, PhD, Erasmus MC - Sophia Children's Hospital

Disclosures:
No relevant conflicts of interest to declare.
7:00 AM

Kirsten Canté-Barrett, PhD1, Jill AP Spijkers-Hagelstein2*, Jessica GCAM Buijs-Gladdines1*, Wilco K Smits1*, Rogier C Buijsman, PhD2*, Guido JR Zaman, PhD2*, Rob Pieters, MD, PhD1,3 and Jules PP Meijerink, PhD1

1Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
2Netherlands Translational Research Center B.V., Oss, Netherlands
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

7:15 AM

Takaya Moriyama, MD1,2, Julia Meyer, PhD3,4*, Shuguang Liu, PhD1,5*, Xujie Zhao1*, Zhaohong Ying, MD1*, William L. Carroll, MD3,4,6 and Jun J Yang, PhD7

1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
3New York University Cancer Institute, New York University Langone Medical Center, New York, NY
4Department of Pathology, New York University Langone Medical Center, New York, NY
5Hematology Oncology Center, Beijing Children’s Hospital, Beijing, China
6Department of Pediatrics, New York University Langone Medical Center, New York, NY
7Dep. Pharm. Sci., Hematologic Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN

7:30 AM

Melinda Burgess1,2*, Sally Mapp, MBBS, PhD, FRACP, FRCPA3,4*, Roberta Mazzieri, PhD1,2*, Jonathan Ellis, BSc, MSc, PhD1,2*, Catherine Cheung4*, Lynne Chambers3*, Stephen Mattarollo, BSc, PhD1,2*, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA2,4,5, Devinder Gill, MB FRCPath FRACP FRCPA2,6 and Nicholas Saunders, BSc, PhD1,2*

1University of Queensland Diamantina Institute, Brisbane, Australia
2Translational Research Institute, Brisbane, Australia
3Haematology Dept, Princess Alexandra Hospital, Brisbane, Australia
4School of Medicine, University of Queensland, Brisbane, Australia
5Princess Alexandra Hospital, Brisbane, Australia
6Haematology, Princess Alexandra Hospital, Brisbane, Australia

7:45 AM

Kallesh D. Jayappa, Ph.D.1*, Craig A. Portell, MD2,3, Vicki Gordon, B.S.1*, Michael E. Williams, MD2,4, Emanuel F. Petricoin, Ph.D.5*, Timothy P. Bender, PhD1,6* and Michael J. Weber, PhD1,2*

1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA
2Cancer Center, University of Virginia, Charlottesville, VA
3Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA
4Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA
5Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA
6Beirne B. Carter Center for Immunology Research, University of Virginia School of Medicine, Charlottesville, VA

8:00 AM

Jae H Park, MD1, Stephen S. Chung, MD1, Benjamin Durham, MD, PhD2*, Young Rock Chung, MS3*, Sasinya Scott, MPH2*, Bartlomiej Getta, MBBS,2*, Eunhee Kim, PhD2*, Alan Saven, MD4, Richard M. Stone, MD5, Kanti R Rai, MD6, Michael R. Grever, MD7, Jessica K. Altman, MD8, Neal Rosen, MD, PhD9*, Ross L. Levine, MD2, Michael Berger, PhD10*, Martin S Tallman, MD1 and Omar Abdel-Wahab2

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
4Scripps Health, La Jolla, CA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6North Shore Long Island Jewish Health Systems, New Hyde Park, NY
7Division of Hematology and Oncology, The Ohio State University, Columbus, OH
8Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
9Pharmacology, Memorial Sloan Kettering Cancer Center, New York
10Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

8:15 AM

Chang-Xin Shi, Ph.D.1*, Klaus M Kortum, M.D.1*, Yuan Xiao Zhu, PhD1*, Patrick Jedlowski1*, Esteban Braggio, PhD1, Laura Ann Bruins2*, Patrick G. Votruba, M.S.3*, Moulun Luo, Ph.D.4*, Robert A. Stewart5*, Jonathan M. Ahmann5* and A. Keith Stewart2

1Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
2Mayo Clinic, Scottsdale, AZ
3Department of Infomation Techonology, Mayo Clinic, Scottsdale
4Mayo/ASU Center for Metabolic and Vascular Biology, Arizona State University, Scottsdale
5Division of Hematoloty/Oncology, Mayo Clinic, Scottsdale

*signifies non-member of ASH